Vicente Descalzo Jorro Institutions of which they are part Infectious Diseases Vall Hebron Institut de Recerca Email Vicente Descalzo Jorro Email Institutions of which they are part Infectious Diseases Vall Hebron Institut de Recerca
Projects Malalties infeccioses IP: Vicenç Falcó Ferrer Collaborators: Jose Santos Santiago, Maria Luisa Aznar Ruiz de Alegria, Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Oscar Len Abad, Mª Carmen Ferrer Barberà, Javier Gomis Rodriguez, Diana Pou Ciruelo, Begoña Treviño Maruri, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juan Espinosa Pereiro, Bibiana Planas Ribas, Ma Dolores Rodríguez Pardo, Pau Bosch Nicolau, David Perea Pérez, Israel Molina Romero, Patricia Álvarez López, Malalties infeccioses, Vicente Descalzo Jorro, Marta Sanchiz Cruz, Nuria Serre Delcor, Malalties infeccioses, Julia Sellares Nadal, Fernando M Salvador Velez, Isabel Ruiz Camps, Jordi Gómez i Prat, María José Buzón Gómez, Hakima Ouaarab Essadek, Paula Suanzes Diez, Jordi Navarro Mercadé, Esperanza Esteban Serna, Raisa Morales Martinez, Joaquin Burgos Cibrian, Nerea Sanchez Gaona, Joan Rey Cano, Adrián Sánchez Montalvá, Cristina Mancebo Perez, Montserrat Llinás Vidal, Ana Gallego Cortes, Maider Arando Lasagabaster, Ibai Los Arcos Bertiz, Claudia Broto Cortes, Malalties infeccioses, Malalties infeccioses, Malalties infeccioses, Meritxell Genesca Ferrer, Ines Mercedes Oliveira Souto, Silvina Andrea Magnani, Yasmine Margaret Baktash Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 00764 Duration: 01/01/2022 - 30/06/2025 Enhancing CD8+ Resident Memory T cell function to control and eliminate viral reservoirs IP: Meritxell Genesca Ferrer Collaborators: Vicente Descalzo Jorro, Josep Castellví Vives, Laura Mañalich Barrachina Funding agency: Instituto de Salud Carlos III Funding: 171820 Reference: PI20/00160 Duration: 01/01/2021 - 30/06/2025 Impact of early treatment during acute HIV infection on the metabolism of reservoir and immune effector cells: Identification of new targets to reduce persistent HIV IP: Jordi Navarro Mercadé Collaborators: Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Vicenç Falcó Ferrer, Bibiana Planas Ribas, Vicente Descalzo Jorro, Paula Suanzes Diez, Judit Grau Exposito Funding agency: Instituto de Salud Carlos III Funding: 87120 Reference: PI20/00823 Duration: 01/01/2021 - 30/06/2025 Pre-clinical evaluation of safety and immunogenicity of recombinant BCG expressing SIV:consv in Cynomolgus macaques. A new platform for a bivalent HIV/TB vaccine development IP: Joan Joseph Munné Collaborators: Vicente Descalzo Jorro Funding agency: Instituto de Salud Carlos III Funding: 147620 Reference: PI20/00217 Duration: 01/01/2021 - 30/06/2025
